- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 28.02. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 27.02. | QT Imaging receives $10.1M in new funding | 1 | Seeking Alpha | ||
| 12.02. | QT IMAGING HOLDINGS, INC. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 05.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 05.02.2025 | 755 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 05.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 05.02.2025ISIN NameCA75525M1095 RAZOR... ► Artikel lesen | |
| QT IMAGING Aktie jetzt für 0€ handeln | |||||
| 31.01. | QT IMAGING HOLDINGS, INC. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 24.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 16.01. | QT Imaging files to sell 8.81M shares of common stock for holders | 1 | Seeking Alpha | ||
| 16.01. | QT IMAGING HOLDINGS, INC. - S-1, General form for registration of securities | - | SEC Filings | ||
| 13.01. | QT Imaging sichert finanzielle Grundlage und prognostiziert Wachstum | 1 | Investing.com Deutsch | ||
| 10.01. | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 20.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.12.24 | QT Imaging announces new commercial shipment in partnership with Couri Center | 1 | Seeking Alpha | ||
| 11.12.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.24 | QT Imaging Holdings GAAP EPS of -$0.17, revenue of $0.96M | 3 | Seeking Alpha | ||
| 13.11.24 | QT Imaging Announces Third Quarter 2024 Financial Results | 151 | Business Wire | NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative... ► Artikel lesen | |
| 13.11.24 | QT IMAGING HOLDINGS, INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 12.11.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 01.11.24 | QT IMAGING HOLDINGS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09.24 | QT Imaging ändert Vereinbarung zur Verlängerung der Laufzeit | 1 | Investing.com Deutsch | ||
| 30.09.24 | QT Imaging Amends Agreement to Extend Maturity Date | 1 | Investing.com |
Seite:
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 498,40 | -5,25 % | Intuitive Surgical Aktie: Das sagen aktuelle Marktberichte | Der Aktienkurs von Intuitive Surgical zeigt sich am 01. März 2025 mit einem Kurs von 552,45 EUR nahezu unverändert gegenüber dem Vortag. Trotz eines Monatsverlusts von 1,80% verzeichnet der führende... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,120 | -3,69 % | Sernova Biotherapeutics Inc: Sernova arranges $1-million debenture financing | ||
| ATOSSA THERAPEUTICS | 0,717 | +3,76 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Responds to PTAB Ruling on U.S. Patent No. 11,572,334 and Announces the Issuance of U.S. Patent No. 12,201,591 | SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,970 | -3,10 % | Ping An Healthcare and Technology Company Limited: Ping An Health Pioneers AI-Driven Healthcare with DeepSeek Integration | HONG KONG and SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,019 | +8,05 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,446 | -0,45 % | Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance | The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/... ► Artikel lesen | |
| CYTOSORBENTS | 0,923 | -11,93 % | Cytosorbents Corp - 8-K, Current Report | ||
| VERU | 0,491 | +1,32 % | Veru Inc.: Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress | --Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,757 | -0,07 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
| VOLITIONRX | 0,599 | +1,01 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
| EKSO BIONICS | 0,381 | -6,39 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 0,820 | -0,61 % | Imunon, Inc.: IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in... ► Artikel lesen | |
| BEYOND AIR | 0,264 | 0,00 % | Beyond Air Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update | Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; international... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,578 | -1,53 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights |
Das Unternehmen QT IMAGING HOLDINGS INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,114 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QT IMAGING HOLDINGS INC finden Sie auf Wallstreet Online.
